【レポートの概要（一部）】
1. Report Overview
1.1 Overview of Biosimilar Monoclonal Antibodies: R&D, Industry and Market
1.2 Why You Should Read this Report
1.3 How This Study Delivers
1.4 Main Questions Answered by the Analysis
1.5 Who is This Investigation For?
1.6 Method of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Associate visiongain Reports
1.9 About visiongain
2. Introduction to Biosimilar Monoclonal Antibodies
2.1 Natural Antibodies: Key to the Immune System
2.2 From Serum therapy to Monoclonal Antibodies
2.3 Humanising the mAb
2.4 Biologics (Biological Drugs) and Biosimilars
2.5 Why are Biosimilars in High Demand?
2.6 Considerations for the Development of Biosimilars
2.6.1 Biologics and Biosimilars Are Large, Complex Molecules
2.6.2 How Much of a Concern is Immunogenicity?
2.7 Biosimilar Monoclonal Antibodies Currently on the Market
3. The Global Market for Biosimilar Monoclonal Antibodies, 2016-2026
3.1 The Present Global Market for Biosimilar Monoclonal Antibodies
3.2 The Global Market for Biosimilar mAbs: A Revenue Forecast, 2016-2026
3.3 The Global Market for Biosimilar mAbs by Compound: Predictions for Revenue and Market Share in 2020 and 2026
3.4 The World Market for Biosimilar mAbs by Compound: Revenue Forecasts, 2016-2026
3.4.1 Will Biosimilar Versions of Monoclonal Antibodies Capture a Large Proportion of the Market?
3.4.2 Biosimilar Infliximab: Currently the Second Largest Submarket
3.4.2.1 Biosimilar Infliximab Revenue Forecast 2016-2026
3.4.3 Biosimilar Rituximab: The current Leading Submarket Driven by Sales in Russia
3.4.3.1 Biosimilar Rituximab: Revenue Forecast 2016-2026
3.4.4 Biosimilar Abciximab: Revenue Forecast 2016-2026
3.4.4.1 Biosimilar Abciximab: Revenue Forecast, 2016-2026
3.4.5 Biosimilar Trastuzumab: Pipeline Rich in Phase III Candidates
3.4.5.1 Biosimilar Trastuzumab: Revenue Forecast, 2016-2026
3.4.6 Biosimilar Adalimumab: Patents Hold Back Revenue on a Large Pipeline
3.4.6.1 Biosimilar Adalimumab: Revenue Forecast 2016-2026
3.4.7 Biosimilar Bevacizumab: Will Late Entry to the Biosimilar mAb Market Restrict Revenue?
3.4.7.1 Biosimilar Bevacizumab: Revenue Forecast, 2016-2026
3.5 Drivers and Restraints for the Biosimilar mAb market 2016-2026
3.5.1 Driving Factors of the Biosimilar mAb Market 2016-2026
3.6 Restraining Factors of the Biosimilar mAb Market 2016-2026
4. Individual Biosimilar mAb Products: Marketed and Pipeline Drugs, 2016-2026
4.1 Biosimilar mAbs on the Market in 2015
4.1.1 Celltrion’s Remsima/ Hospira’s Inflectra. Egis’ Flammegis (Infliximab): The First Official Biosimilar Monoclonal Antibody
4.1.1.1 Remsima/Inflectra/Flammegis Revenue Forecast, 2016-2026
4.1.2 Infimab (Infliximab): Launched a Quarter Ahead of Schedule
4.1.2.1 Infimab Revenue Forecast ($m) 2016-2026
4.1.2.2 Dr Reddy’s Reditux (Rituximab): No Application for EU or US Approval
4.1.2.3 Reditux Revenue Forecast, 2016-2026
4.1.3 Intas Pharmaceuticals’ Mabtas (Rituximab)
4.1.3.1 Mabtas (Rituximab) Revenue Forecast 2016-2026
4.1.4 AcellBia (Rituximab): Sales in Russia Generating Large Revenue Figures
4.1.4.1 AcellBia Revenue Forecast 2016-2026
4.1.5 MABALL: Faces Competition from other Biosimilar Rituximabs in India
4.1.5.1 MABALL Revenue Forecast, 2016-2026
4.1.6 Isu Abxis’ Clotinab (abciximab):
4.1.6.1 Clotinab Revenue Forecast, 2016-2026
4.1.7 AbcixiRel: The First Indian Abciximab Biosimilar
4.1.7.1 AbcixiRel Revenue Forecast 2016-2026
4.1.8 Herzuma (Trastuzumab): Approved in South Korea
4.1.8.1 Herzuma Revenue Forecast 2016-2026
4.1.9 CANMAb/Hertraz (Trastuzumab)
4.1.9.1 CANMAb/Hertraz Revenue Forecast, 2016-2026
4.2 Pipeline Biosimilars
4.2.1 BI695500 (Rituximab): An EU Launch Anticipated in 2017
4.2.1.1 BI695500 Revenue Forecast, 2016-2026
4.2.2 CT-P10 (Rituximab): Celltrion’s Reputation for Biosimilars will Assist Sales
4.2.2.1 Celltrion’s CT-P10 (Rituximab) Revenue Forecast, 2016-2026
4.2.3 Boehringer Ingelheim’s BI695501 (Adalimumab)
4.2.3.1 BI695501 Revenue Forecast, 2016-2026
4.2.4 BCD-022 (Trastuzumab): Currently under Development in Russia Only
4.2.4.1 BCD-022 Revenue Forecast, 2016-2026
4.2.5 Fujifilm Kyowa Kirin Biologics’ FKB327 (Adalimumab)
4.2.5.1 FKB327 Revenue Forecast, 2016-2026
4.2.6 Fujifilm Kyowa Kirin Biologics’ FKB238 (Bevacizumab)
4.2.6.1 Fujifilm Kyowa Kirin Biologics’ FKB238 Revenue Forecast 2016-2026
4.2.7 BCD-021 (Bevacizumab): Russia Will Contribute the Most Revenue
4.2.7.1 BCD-021 Revenue Forecast 2016-2026
5. Leading National Markets for Biosimilar Monoclonal Antibodies
5.1 What Were the Leading National Markets for Biosimilar mAbs in 2015?
5.2 How Will National Market Shares Change Over the Forecast Period?
5.3 India: The Current Leading Nation for Biosimilar mAbs but Growth will Slow
5.3.1 India Releases New Biosimilar Development Guidelines
5.3.2 Indian Biosimilar Submarket Forecast 2016-2026
5.4 Russia: Lack of Regulatory Framework Works Well in the Short Term
5.4.1 Russian Government Backed ‘Pharma 2020’ Initiative
5.4.2 Russian Biosimilar mAb Revenue Forecast, 2016-2026
5.4 South Korean Market has Benefitted from Early Biosimilar Guidelines
5.4.1 Significant Investment in Biosimilars in South Korea
5.4.2 South Korean Biosimilar mAb Revenue Forecast, 2016-2026
5.5 China: A Fragmented Biosimilar mAb Market
5.5.1 Chinese FDA Publishes Finalised Biosimilar Guidelines in 2015
5.5.2 China Biosimilar mAb Revenue Forecast, 2016-2026
5.6 Brazil: ANVISA’s Biosimilar Regulations Are Similar the EMA’s
5.6.1 Brazil Biosimilar mAb Revenue Forecast 2016-2026
5.7 The Outlook for Biosimilar mAbs in the EU 2016-2026
5.7.1 Updating Biosimilar Regulation: Guidelines for the Specific Approval of Biosimilar mAbs
5.7.2 Biosimilar mAbs in the EU5: Revenue Forecasts, 2016-2026
5.7.3 Germany: the Current EU Leader
5.7.4 France: Will the Uptake of Biosimilar mAbs be Restricted?
5.7.5 UK: NICE Recommends Use of Remsima for Certain Indications
5.7.6 Italy: Healthcare Spending Cuts Will Drive Growth
5.7.7 Spain: High Biosimilar mAb Discounts Expected
5.8 The Outlook for Biosimilar mAbs in Japan
5.8.1 Regulations for Naming Biosimilars
5.8.2 Biosimilar mAb Market Activity in Japan
5.8.3 Japanese Biosimilar Submarket Forecast 2016-2026
5.9 US Biosimilar mAb Outlook: None Currently on the Market
5.9.1 US FDA Biosimilar Guidelines were Released in 2015
5.9.2 Legal Challenges for Biosimilars in the US
5.9.3 State Regulation of Biosimilar Substitution
5.9.4 The US Biosimilar mAb Market Revenue Forecast, 2016-2026
6. Leading Companies in Biosimilar Monoclonal Antibodies
6.1 Collaboration in Biosimilar mAb Development
6.2 BioXpress: Targeting Patent Expiry Dates in 2019-2023
6.3 Celltrion: Company’s Market Value Surges to Exceed $10.7bn
6.4 Harvest Moon: Six Compounds Under Development
6.5 Genor Biopharma: A Biosimilar mAb Market Leader in China
6.6 Samsung Bioepsis
6.7 Mabion: Poland’s Leading Biosimilar mAb Developer
6.8 Gene Techno Science: Substantial Revenue Increases Since 2014
6.9 India’s Biocon:
6.10 Coherus Biosciences
6.11 BIOCAD: World Leader Biosimilar Rituximab Sales
6.12 Big Pharma and the Biosimilar mAb Market
6.13 Significant Acquisitions in the Biosimilar mAb Market
6.13.1 Pfizer Acquires Hospira
6.13.2 Epirus Acquires Bioceros
7. Qualitative Analysis of Biosimilar Monoclonal Antibodies
7.1 Strengths and Weaknesses of the Biosimilar Monoclonal Antibody Market, 2016-2026
7.1.1 Global Demand for Affordable Biopharmaceuticals has Never Been Greater
7.1.2 Adoption of Biosimilar mAbs will be Proportional to the Rate of Discount
7.1.3 Approval Pathways are Now Established in Developed Markets
7.1.4 Complexity of Protein Molecules Leads to Technical Challenges
7.1.5 Doctor and Patient Confidence May Take Time
7.2 Opportunities and Threat Facing the Biosimilar Monoclonal Antibody Market, 2016-2026
7.2.1 Market Opportunities from Patent Expiries and a Well-stocked Pipeline
7.2.2 Substitution may Not Occur Automatically
7.2.3 Biobetters Offer a Serious Threat to the Production and Uptake of Biosimilars
7.3 Social and Technological Forces Influencing the Biosimilar Monoclonal Antibodies Market 2016-2026
7.3.1 Social Factors: Driving or Restraining the Market?
7.3.2 Technological Factors Concentrate on Reducing Costs and Increasing Ease of Production
7.3.3 Economic Pressures Raise Demand for Biosimilar mAbs
7.3.3.1 Fragmentation of the Market Could Limit Individual Drug Revenues
7.3.4 Political Issues: Stringent Regulations Hurdles to Market Entry
8. Research Interviews
8.1 Interview with Professor Steve Morgan, UBC
8.1.1 On the Benefits of mAbs
8.1.2 On the FDA Biosimilar Regulatory Pathway
8.1.3 On the Challenges in Bringing Biosimilar mAbs to Market
8.1.4 On the Rate of Uptake of Biosimilar mAbs
8.1.5 On What Can be Learnt From Previous Case Studies
8.2 Interview with Dr. Seoyoung C. Kim, Harvard
8.2.1 On the use of Remsima in Korea
8.2.2 On Adoption Rates of Biosimilar Infliximab in the US
8.2.3 On the Indications for Biosimilar Infliximab
9. Conclusions From our Study
9.1 Biosimilar Monoclonal Antibodies: World Market, 2016-2026
9.2 Future of Compounds on the Market and in the Pipeline
9.3 Leading National Markets for Biosimilar Monoclonal Antibodies 2016-2026
9.4 Leading Companies in the Biosimilar mAb Market
9.5 Current and Expected Industry Trends 2016-2026
9.5.1 Cost Control of Healthcare Will Work in Favour mAbs
9.5.2 Upcoming Patent Expiries in Developed Markets Offer Large Market Potential
9.5.3 Complex Production Processes are a Restraining Factor
9.5.4 Clinician and Patient Confidence Must be Maximised to Ensure Uptake
9.5.5 Biobetters Pose a Threat
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
【レポート販売概要】
■ タイトル：バイオシミラー・モノクローナル抗体の世界市場：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、ベバシズマブ、アブシキシマブ■ 英文：Biosimilar Monoclonal Antibodies Market Forecast 2016-2026 : Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
■ 発行日：2016年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041527
■ 調査対象地域：グローバル
- 自動車安全装置向け光学レンズの世界市場2016-2020About Automotive Camera Automotive camera modules are devices that are installed in the front, rear, and side of the automobiles to provide maximum information about the surroundings and help in preventing and minimizing the impact of accidents, in turn protecting both passengers and pedestrians. These camera modules warn the driver by providing a clear image of the rear and side blind zones, cons …
- アメリカのネット通販市場2016-2020About Online Retail Market The retail industry can be divided into two broad segments: brick-and-mortar retail and online retail. Brick-and-mortar retail is also known as offline retail or physical store-based retail. Online retail is a part of B2C e-commerce and typically refers to commerce activities over the Internet. A wide range of products are sold in the online retail market, and these broa …
- 建設用ファブリックの世界市場2019-2023About this market Increasing demand for textile reinforced concrete to drive market growth. Textile reinforced concrete (TRC) is a composite material in which fabrics are used as reinforcement to bring significant loads in tension that can further be used in thin cross-sections. TRC is used in the construction of bridges, arenas, parking garages, houses, silos, towers, and other infrastructures. T …
- パルスオキシメーターの世界市場：種類別（指先型、ハンドヘルド型）、最終用途（病院・医療施設、在宅医療）、地域別、セグメント予測The global pulse oximeters market size is expected to reach USD 2.8 billion by 2025, based on a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.3% during the forecast period. The growth can be attributed to high prevalence of target diseases, such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, cardiac arrhythmia, and ischemic conditions. Pulse oxim …
- ファシリティ・マネジメントのグローバル市場(2014-2019)Across verticals several organizations are exhibiting high levels of interest in deploying IT solutions and systems. The prime reason for this would be the ease these solutions bring in the organization. These solutions bring transparency in operations and processes, and align support functional processes with core operations in the business. IT based facility management solutions or CAFM solution …
- 冷凍パン類製品の世界市場予測（～2022）：種類別（パン、ピザクラスト、ケーキ＆ペーストリー）、販売チャンネル別、技術別An excellent growth has been recorded in the global frozen bakery products market over the last couple of decades. The market size is projected to reach USD 23.48 Billion by 2022, at a CAGR of around 7.9% from 2016. Increase in demand for convenient food products and drive for greater taste, safety, and consistency are the major factors driving the global frozen bakery products market. Emerging co …
- 世界のおむつ（Diaper）製品市場（2014-2018）TechNavio's analysts forecast the Global Diaper market to grow at a CAGR of 4.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased average disposable income. The Global Diaper market has also been witnessing the increased R&D investments by the vendors. However, the declining birth rates in developed markets could pose a challenge to the …
- Kinder Morgan Energy Partners, L.P.：石油・ガスバリューチェーン分析レポート2013Kinder Morgan Energy Partners, L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Kinder Morgan Energy Partners, L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Kinder Morgan Energy Partners, L.P.”. The report provides key information relating to oil and gas assets of the company along with its opera …
- インドの工作機械市場2016-2020About the Machine Tools Market Machine tools are used to cut and shape metals and other materials based on the specifications of a product. They provide an effective and efficient method of manufacturing critical components with ease and accuracy. Machine tools can be either computer numeric controlled (CNC) or non-CNC. Non-CNC tools are also known as conventional machine tools, and are classified …
- 感染症診断の世界市場展望2017-2026According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and ris …
- KenyaのCarpets and Other Textile Floor Coverings市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Kenya and its perspectives on the global market for Carpets and other textile floor сoverings. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Carpets and other textile floor сoverings export/import operations …
- PT Medco Energi Internasional Tbk：石油・ガスの開発・生産動向及びコスト分析- 2012PT Medco Energi Internasional Tbk Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary PT Medco Energi Internasional Tbk Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is …
- RFIDスマート・アンテナの世界市場2016-2020About the RFID Smart Antenna Market An RFID system is a wireless technology that uses radio waves to receive data from a tag attached to an object. It is used for various purposes such as tracking objects and automatic identification. Components of RFID systems are as follows: • Tag (attached to an object: unique identification) • Antenna (tag detector: creates magnetic field) • Reader (receiver o …
- クリーンルーム用ロボットの世界市場2016-2020About the Cleanroom Robots Market A cleanroom is a well-maintained environment with minimum levels of environmental pollutants such as aerosols, dusts, chemicals, and microbes. It has strict specifications about the number of particles per cubic meter and regarding particle size. It is typically used for manufacturing products, which require highly sterile and dust-free environment such as semicon …
- 自動車補修用塗料の世界市場2016-2020：溶剤型塗料、水性塗料About Automotive Refinish CoatingsAutomotive coatings are products that enhance the exterior appearance and durability of a vehicle by protecting it from harsh external factors such as UV radiation, heat and cold, and grit from the road. Automotive refinish coatings are used for automotive aftermarket purposes such as vehicle repair and refinishing. Technavio’s analysts forecast the global automot …
